📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
40
Warrant Exposure
40
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration
15%
• Score climbed 5 points (worsening)
💹 Market Data
Market CapN/A
Shares OutstandingN/A
Float26.12M
Cash$2.61M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest338
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ARTCW
📊 ARTCW FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ARTCW Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.